Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
10/21/1998 | EP0871627A1 Novel substituted azacyclic or azabicyclic compounds |
10/21/1998 | EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
10/21/1998 | EP0871615A1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors |
10/21/1998 | EP0871613A1 Benzyl piperidine derivatives as pharmaceutical agents |
10/21/1998 | EP0871488A1 Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and a kappa-2 opioid agonist |
10/21/1998 | EP0871473A1 Pharmaceutical composition containing il-10 |
10/21/1998 | EP0871445A1 Composition for treating pain |
10/21/1998 | EP0871442A1 Benzimidzolyl neuropeptide y receptor antagonists |
10/21/1998 | EP0871440A1 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
10/21/1998 | EP0871439A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
10/21/1998 | EP0871420A1 Triacetin as a transdermal penetration enhancer |
10/21/1998 | EP0788795A4 Pharmacologically active 2-mercaptobenzimidazole derivatives |
10/21/1998 | EP0710229B1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
10/21/1998 | EP0710227B1 Vitamin d analogues |
10/21/1998 | EP0613560B1 A method for assaying and treating alzheimer's disease |
10/21/1998 | CN1196729A Novel heterocyclic compounds |
10/21/1998 | CN1196728A Prolylendopeptidase inhibitors |
10/21/1998 | CN1196720A Novel vitamin D analogues |
10/21/1998 | CN1040327C Pyrido [2,3-d) pyrimidine-2,4-(1H, 3H)-diones and -2(1H,3H)-ones, manufacture method and use thereof |
10/20/1998 | US5824784 Genetic engineering with polypeptides and proteins |
10/20/1998 | US5824775 Human netrin-1 |
10/20/1998 | US5824771 Cyclic corticotropin-releasing factor peptides |
10/20/1998 | US5824678 Morpholine derivatives and their use as therapeutic agents |
10/20/1998 | US5824673 Pharmaceutical compositions comprising metal complexes |
10/20/1998 | US5824671 Vaginal atrophy, hypogonadism and loss of collagen or connective tissues |
10/20/1998 | US5824504 Polynucleotides |
10/16/1998 | CA2234789A1 New naphthylpiperazine derivatives |
10/15/1998 | WO1998045441A1 Human gtp binding protein |
10/15/1998 | WO1998045434A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
10/15/1998 | WO1998045427A2 Insulin-like growth factor agonist peptides |
10/15/1998 | WO1998045332A2 Humanized antibodies and methods for forming humanized antibodies |
10/15/1998 | WO1998045331A2 Anti-vegf antibodies |
10/15/1998 | WO1998045327A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
10/15/1998 | WO1998045322A2 Diagnosis method and reagents |
10/15/1998 | WO1998045297A1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES__ |
10/15/1998 | WO1998045294A1 Compounds |
10/15/1998 | WO1998045293A1 Pyrimido-isoquinoline compounds with anticonvulsive action |
10/15/1998 | WO1998045287A1 Treatment of central nervous system disorders with selective estrogen receptor modulators |
10/15/1998 | WO1998045285A1 Somatostatin agonists |
10/15/1998 | WO1998045270A1 Pharmacological agents |
10/15/1998 | WO1998045268A1 Nicotinamide derivatives |
10/15/1998 | WO1998045263A1 Analogs of cocaine |
10/15/1998 | WO1998045256A1 Hydroxamic acid derivatives |
10/15/1998 | WO1998044955A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
10/15/1998 | WO1998044936A2 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations |
10/15/1998 | WO1998044922A1 Somatostatin agonists |
10/15/1998 | WO1998044921A1 Somatostatin agonists |
10/15/1998 | WO1998044920A1 Use of halo and/or nitro-substituted flavonoids as anxyolitics |
10/15/1998 | WO1998018925A3 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |
10/15/1998 | DE19714450A1 Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitung Stable extract of Hypericum perforatum L., process for its preparation and pharmaceutical preparation |
10/15/1998 | CA2287293A1 Somatostatin agonists |
10/15/1998 | CA2287084A1 Diagnosis method and reagents |
10/15/1998 | CA2286455A1 Treatment of central nervous system disorders with selective estrogen receptor modulators |
10/15/1998 | CA2286452A1 Pyrimido-isoquinoline compounds with anticonvulsive action |
10/15/1998 | CA2286305A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
10/15/1998 | CA2286283A1 Human gtp binding protein |
10/15/1998 | CA2286264A1 Insulin-like growth factor agonist peptides |
10/15/1998 | CA2286064A1 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations |
10/15/1998 | CA2285906A1 Hydroxamic acid derivatives |
10/15/1998 | CA2285604A1 Somatostatin agonists |
10/15/1998 | CA2285388A1 Compounds |
10/15/1998 | CA2285223A1 Somatostatin agonists |
10/15/1998 | CA2285192A1 Pharmacological agents |
10/15/1998 | CA2285020A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
10/15/1998 | CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor |
10/14/1998 | EP0870825A1 Human protein kinases hYAK3 |
10/14/1998 | EP0870768A1 Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
10/14/1998 | EP0870760A1 Cyclopropyl glycine derivatives with pharmaceutical properties |
10/14/1998 | EP0870759A1 Aminated 6,7,8,9-tetrahydro-cyclopenta[a]naphtalene- and 2,3-dihydro-cyclopenta[e]indene-derivatives, process for their preparation and pharmaceutical compsitions containing them |
10/14/1998 | EP0870757A2 Fluoro-substituted adamantane derivatives |
10/14/1998 | EP0870499A1 Oral use of (+)-0-Demethyltramadol as analgesic |
10/14/1998 | EP0870038A1 INTERLEUKIN-1$g(b) CONVERTING ENZYME LIKE CYSTEINE PROTEASE |
10/14/1998 | EP0870019A2 Cell activation process and reagents therefor |
10/14/1998 | EP0869975A1 Assay for and uses of peptide hormone receptor ligands |
10/14/1998 | EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
10/14/1998 | EP0869958A1 Novel indole-2,3-dione-3-oxime derivatives |
10/14/1998 | EP0869956A1 Pharmaceutical compositions |
10/14/1998 | EP0869955A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
10/14/1998 | EP0869954A1 Novel heterocyclic compounds |
10/14/1998 | EP0869952A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
10/14/1998 | EP0869943A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
10/14/1998 | EP0869791A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
10/14/1998 | EP0869783A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
10/14/1998 | EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
10/14/1998 | EP0764273B1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
10/14/1998 | EP0752982B1 Biphenyl derivatives as 5ht1d antagonists |
10/14/1998 | EP0741743B1 Cyclic neurokinin a antagonists |
10/14/1998 | EP0678090B1 Piperazine derivatives |
10/14/1998 | CN1196057A Substituted phosphinic compounds and their use as pharmaceuticals |
10/14/1998 | CN1196053A Novel heterocyclic compounds for treatment of pain and use thereof |
10/14/1998 | CN1196049A Acylated derivatives of melatonin and its analogues, useful as medicaments |
10/14/1998 | CN1195986A Paroxetine controlled release compositions |
10/14/1998 | CN1195555A Narcotics-giving-up oral liquor and its preparing method |
10/14/1998 | CN1195524A Pharmaceutical formulation |
10/13/1998 | US5821371 Heterocyclic compounds and their preparation and use |
10/13/1998 | US5821370 Muscarinic cholinergic drugs |
10/13/1998 | US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity |
10/13/1998 | US5821365 Compounds as enzyme inhibitors for kinases formed by reaction of amine with anhydride group to form indolmaleimide macrocycles |
10/13/1998 | US5821255 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
10/13/1998 | US5821248 Substance p antagonists |